WAVE LIFE SCIENCES LTD. Dividends Receivable
WAVE LIFE SCIENCES LTD. (WVE) had Dividends Receivable of $30.00 thousand as of 2020-06-30, per its 10-Q filed 2020-08-10.
Discontinued › Notes › Nontrade Receivables
us-gaap:DividendsReceivable · last filed 2020-08-10
- 2020-06-30: Dividends Receivable $30.00K.
- 2020-03-31: Dividends Receivable $104.00K.
- 2019-12-31: Dividends Receivable $200.00K.
| Period end | Dividends Receivable |
|---|---|
| 2020-06-30 | $30.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $104.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $200.00K 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |